Mitochondria‐Targeted Ferroptosis Nanodrug for Triple‐Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition
Small · 2025-10 · 21 (39)
DOI: 10.1002/smll.202506443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 18.08.2025. Verfasst von Yunyi Shan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 211198, China. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Fatty Acids, Mitochondria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Post-doctoral support of Jiangsu Province.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer, due to its pronounced propensity for metastasis. This challenge is amplified by the critical role of mitochondria in metastasis, regulating processes like fatty acid metabolism that drive tumor cell migration. Moreover, emerging evidence suggests that bacterial infiltration, particularly Staphylococcus xylosus ( S. xylosus ), could further exacerbate TNBC metastasis. To address both metabolic dysregulation and bacterial involvement, a mitochondria‐targeted ferroptosis‐activated nanosystem is developed, named ICM, which is integrated the mitochondrial membrane (MM) for mitochondrial targeting, the FeCl 3 for ferroptosis therapy, the photosensitizer indocyanine green, and cytochrome c (CytC) through self‐assembly technology. During assembly, CytC interacted with cardiolipin on the MM, endowing ICM with peroxidase‐like and catalase‐like activities. Dual enzymatic activities, combined with phototherapy, enhance FeCl 3 ‐induced ferroptosis in tumor cell mitochondria, thereby reprogramming fatty acid metabolism and inhibiting metastasis. Additionally, the amplified ferroptosis effects also effectively inhibit S. xylosus , disrupting the tumor‐bacteria symbiosis and further preventing metastatic spread. Finally, ICM nanoparticles significantly suppress TNBC metastasis by modulating lipid metabolism and inhibiting bacterial‐mediated metastasis. These findings suggest that ICM offer a multifaceted therapeutic approach for combating TNBC metastasis, providing a potential strategy for cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 211198, China.
- Key Laboratory of Drug Quality Control and Pharmacovigilance, Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
- Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
- Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
ORCID-Profile: Hui Xiong
Förderung
- Post-doctoral support of Jiangsu Province
Zitieren
APA
Shan, Y., Zhu, X., Wang, T., Zhang, L., Qi, Y., Hu, Z., Jiang, Z., Zhu, Y., Lu, Y., Yao, J., & Xiong, H. (2025). Mitochondria‐Targeted Ferroptosis Nanodrug for Triple‐Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition. Small, 21(39). https://doi.org/10.1002/smll.202506443
Vancouver
Shan Y, Zhu X, Wang T, Zhang L, Qi Y, Hu Z, et al. Mitochondria‐Targeted Ferroptosis Nanodrug for Triple‐Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition. Small. 2025;21(39). doi:10.1002/smll.202506443
BibTeX
@article{Shan2025,
author = {Shan, Yunyi and Zhu, Xiang and Wang, Ting and Zhang, Liang and Qi, Yao and Hu, Zhaoliang and Jiang, Zhijie and Zhu, Yun and Lu, Yuting and Yao, Jing and Xiong, Hui},
title = {Mitochondria‐Targeted Ferroptosis Nanodrug for Triple‐Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition},
journal = {Small},
year = {2025},
volume = {21},
number = {39},
doi = {10.1002/smll.202506443}
}
EUVIMED